Coronavirus Disease 2019 (COVID-19) Sector Forecast: Analyst Consensus Sales Forecast

Coronavirus Disease 2019 (COVID-19) Sector Forecast: Analyst Consensus Sales Forecast



This report contains a summary of the analyst consensus forecasts available in the It Pharma Intelligence Center Drug Sales and Analyst Consensus Database for the Indication COVID-19. Despite the rapid development of COVID-19 therapies being developed the majority of the COVID-19 pipeline is in early stage development so there are few forecasts available. Currently there are three drugs indicated for COVID-19 which have analyst consensus forecasts available.

Scope

This 27-page report gives important, expert insight you wont find in any other source. 7 figures throughout the report illustrate major points and trends in COVID sales forecasts and company pipelines. This report is required reading for -
- Investors that want to understand how COVID-19 has impacted Drug Revenues in the biopharmaceutical industry as well as identifying companies to invest in
- Companies that are interested in entering the COVID-19 disease space
- Large pharma companies with investment groups or BD teams looking for partnership opportunities in the COVID-19 disease space

Reasons to Buy

- Analysis of COVID-19 analyst consensus sales forecasts
- Overview of Pipeline portfolio of companies involved in COVID-19 disease space
- Detailed Analysis of how COVID-19 have affected analyst consensus sales forecasts for previously forecasted Drugs
1 (PowerPoint Deck)
1 COVID-19 Global Analyst Consensus Sales Forecast
2 Gilead Sciences Inc.
2.1 Gilead Sciences Pipeline
2.2 Global Analyst Consensus Sales Forecast - Gilead Sciences Remdesivir
3 CanSino Biologic Inc.
3.1 CanSino Biologic Pipeline
3.2 Global Analyst Consensus Sales Forecast - CanSino Biologics COVID-19 Vaccine
4 Cytodyn Inc.
4.1 Global Analyst Consensus Sales Forecast - Cytodyns Leronlimab
4.2 Archived Global Analyst Consensus Sales Forecast - Cytodyns Leronlimab
5 Key Findings
6 Appendix
6.1 Methodology
6.2 Related Reports
6.3 About the Authors
6.4 About GlobalData
6.5 Contact Us

Coronavirus Disease Vaccines (COVID-19 Vaccines)

Coronavirus Disease Vaccines (COVID-19 Vaccines)The sprint to advance a COVID-19 vaccine is hotly contested. More than 100 vaccines are in preclinical testing, according to 23 companies have moved their candidates

USD 495 View Report

Coronavirus Disease (COVID-19) Implications on Health Insurance - August 2020

Coronavirus Disease (COVID-19) Implications on Health Insurance - August 2020The highly contagious coronavirus (SARS-CoV-2), dubbed COVID-19 (formerly 2019-nCoV), which emerged at the close of 2019, has led to a medical

USD 495 View Report

Coronavirus Disease Vaccines (COVID-19 Vaccines)

Coronavirus Disease Vaccines (COVID-19 Vaccines)The sprint to advance a COVID-19 vaccine is hotly contested. More than 100 vaccines are in preclinical testing, according to 23 companies have moved their candidates

USD 495 View Report

Coronavirus Disease (COVID-19) Implications on Health Insurance - August 2020

Coronavirus Disease (COVID-19) Implications on Health Insurance - August 2020The highly contagious coronavirus (SARS-CoV-2), dubbed COVID-19 (formerly 2019-nCoV), which emerged at the close of 2019, has led to a medical

USD 495 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available